Published in TB and Outbreaks Week, October 21st, 1996
MiKasome is a proprietary liposomal antibiotic designed to improve the efficacy and decrease the toxicity associated with a family of antibiotics known as aminoglycosides. Amikacin, the active ingredient in MiKasome, is a member of the aminoglycoside family.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.